Using combined analysis of GEO and TCGA datasets, it was shown that STEAP3 is hypomethylated and consequently upregulated in glioblastoma, and may be used as a potential methylation-based prognostic biomarker. The gene discussed is STEAP3; the disease is glioblastoma.